共 92 条
[1]
Quigley HA(2006)The number of people with glaucoma worldwide in 2010 and 2020 Br J Ophthalmol 90 262-267
[2]
Broman AT(2002)The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma Arch Ophthalmol 120 701-713
[3]
Kass MA(2002)Reduction of intraocular pressure and glaucoma progression Arch Ophthalmol 120 1268-1279
[4]
Heuer DK(2001)Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery Ophthalmology 108 1943-1953
[5]
Higginbotham EJ(2002)Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication Br J Ophthalmol 86 418-423
[6]
Heijl A(2005)Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review Ophthalmology 112 953-961
[7]
Leske MC(2016)The Maccabi Glaucoma Study: treatment patterns and persistence with glaucoma therapy in a large Israeli health maintenance organization J Glaucoma 25 e386-e391
[8]
Bengtsson B(2011)The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity Ophthalmology 118 2398-2402
[9]
Lichter PR(2016)Self-reported function, health resource use, and total health care costs among medicare beneficiaries with glaucoma JAMA Ophthalmol 134 357-365
[10]
Musch DC(2017)Increasing healthcare costs: can we influence the costs of glaucoma care? Curr Opin Ophthalmol 28 127-132